Journey Medical Corporation
NASDAQ:DERM
3.73 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 79.181 | 73.669 | 63.134 | 44.531 | 34.921 | 42.339 | 4.541 | 22.585 | 7.3 | 7.3 |
| Cost of Revenue
| 26.66 | 30.775 | 32.084 | 14.594 | 10.532 | 1.176 | 0 | 0 | 0 | 0 |
| Gross Profit
| 52.521 | 42.894 | 31.05 | 29.937 | 24.389 | 41.163 | 4.541 | 22.585 | 7.3 | 7.3 |
| Gross Profit Ratio
| 0.663 | 0.582 | 0.492 | 0.672 | 0.698 | 0.972 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 7.541 | 10.943 | 16.558 | 0 | 0 | 80.547 | 104.409 | 83.166 | 66.831 | 30.71 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 172.581 | 71.903 | 30.043 | 17.721 | 8.288 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 43.91 | 59.468 | 39.833 | 22.086 | 19.13 | 172.581 | 71.903 | 30.043 | 17.721 | 8.288 |
| Other Expenses
| 3.143 | 0 | 23.359 | 0 | 0 | 2.017 | 128.555 | 0 | 2.518 | 0 |
| Operating Expenses
| 54.594 | 70.411 | 56.391 | 22.086 | 19.13 | 255.145 | 304.867 | 113.209 | 87.07 | 38.998 |
| Operating Income
| -2.073 | -27.517 | -25.341 | 7.851 | 5.259 | -213.982 | -300.326 | -90.624 | -79.77 | -31.698 |
| Operating Income Ratio
| -0.026 | -0.374 | -0.401 | 0.176 | 0.151 | -5.054 | -66.137 | -4.013 | -10.927 | -4.342 |
| Total Other Income Expenses Net
| -1.559 | -2.048 | -7.479 | -0.698 | -0.255 | -7.752 | -2.935 | 1.54 | 0.749 | -0.146 |
| Income Before Tax
| -3.632 | -29.565 | -42.36 | 7.153 | 5.004 | -221.734 | -303.261 | -89.084 | -79.021 | -31.844 |
| Income Before Tax Ratio
| -0.046 | -0.401 | -0.671 | 0.161 | 0.143 | -5.237 | -66.783 | -3.944 | -10.825 | -4.362 |
| Income Tax Expense
| 0.221 | 0.063 | 1.634 | 1.87 | 1.379 | -0.194 | 5.205 | 3.08 | -0.622 | 0.031 |
| Net Income
| -3.853 | -29.628 | -43.994 | 5.283 | 3.625 | -221.54 | -303.261 | -89.084 | -78.399 | -31.875 |
| Net Income Ratio
| -0.049 | -0.402 | -0.697 | 0.119 | 0.104 | -5.233 | -66.783 | -3.944 | -10.74 | -4.366 |
| EPS
| -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 | -7.48 | -2.7 | -2.93 | -4.96 |
| EPS Diluted
| -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 | -7.48 | -2.7 | -2.93 | -4.96 |
| EBITDA
| 1.921 | -23.181 | -32.766 | 9.367 | 6.438 | -205.54 | -294.782 | -87.421 | -78.802 | -31.644 |
| EBITDA Ratio
| 0.024 | -0.373 | -0.401 | 0.21 | 0.187 | -4.855 | -64.916 | -3.871 | -10.795 | -4.335 |